Correlation Between Tscan Therapeutics and Small Cap
Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and Small Cap at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and Small Cap into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tscan Therapeutics and Small Cap Premium, you can compare the effects of market volatilities on Tscan Therapeutics and Small Cap and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of Small Cap. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and Small Cap.
Diversification Opportunities for Tscan Therapeutics and Small Cap
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Tscan and Small is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and Small Cap Premium in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Small Cap Premium and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with Small Cap. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Small Cap Premium has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and Small Cap go up and down completely randomly.
Pair Corralation between Tscan Therapeutics and Small Cap
Given the investment horizon of 90 days Tscan Therapeutics is expected to generate 13.88 times more return on investment than Small Cap. However, Tscan Therapeutics is 13.88 times more volatile than Small Cap Premium. It trades about 0.06 of its potential returns per unit of risk. Small Cap Premium is currently generating about 0.08 per unit of risk. If you would invest 201.00 in Tscan Therapeutics on September 3, 2024 and sell it today you would earn a total of 276.00 from holding Tscan Therapeutics or generate 137.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tscan Therapeutics vs. Small Cap Premium
Performance |
| Timeline |
| Tscan Therapeutics |
| Small Cap Premium |
Tscan Therapeutics and Small Cap Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tscan Therapeutics and Small Cap
The main advantage of trading using opposite Tscan Therapeutics and Small Cap positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, Small Cap can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Small Cap will offset losses from the drop in Small Cap's long position.| Tscan Therapeutics vs. DiaMedica Therapeutics | Tscan Therapeutics vs. Lyra Therapeutics | Tscan Therapeutics vs. Centessa Pharmaceuticals PLC |
| Small Cap vs. RiverNorth Specialty Finance | Small Cap vs. Royce Micro Cap | Small Cap vs. First Trust Enhanced | Small Cap vs. Ready Capital |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |